灵康药业集团股份有限公司关于控股股东部分股份解除质押的公告

Core Viewpoint - The announcement details the release of a portion of shares pledged by the controlling shareholder of Lingkang Pharmaceutical, indicating a positive development for the company's financial stability and shareholder confidence [2]. Group 1: Shareholder Information - The controlling shareholder, Lingkang Holdings Group Co., Ltd., directly and indirectly holds 339.6528 million shares of Lingkang Pharmaceutical, accounting for 47.09% of the total share capital [2]. - The shares being released from pledge amount to 49.6596 million shares, which represents 14.62% of the shares held by Lingkang Holdings and 6.89% of the total share capital of the company [2]. Group 2: Future Plans - There are currently no plans for subsequent pledges of the released shares, and any future changes will be disclosed in accordance with relevant laws and regulations [2].